SolutionSolution
Schedule H (Prescription Required)Antibacterial Eye & Ear DropsCode: 2641

Tobramycin 0.3% w/v + Fluoromethalone 0.1% w/v Opthalmic Solution

Generic Formulation:Tobramycin 0.3% w/v and Fluoromethalone 0.1% w/v Opthalmic Solution IP
Pack Size:5ml in Mono-carton

MRP Under Process

Official PMBI MRP is being updated for catalog code 2641.

Locate Jan Aushadhi Kendra
Clinical InformationReport Error

Clinical Overview

Tobramycin and Fluorometholone ophthalmic suspension is an antibacterial and surface-selective corticosteroid combination. Tobramycin (0.3%) provides bactericidal coverage against Gram-negative ocular bacilli including Pseudomonas aeruginosa, while fluorometholone (0.1%) delivers targeted corneal and conjunctival anti-inflammatory action with significantly lower intraocular pressure elevation than dexamethasone. Indicated for steroid-responsive inflammatory ocular conditions with secondary bacterial infection risk.

AI-assistedClinical summary synthesized from pharmacopoeial references (CDSCO, WHO EML, IP/BP/USP). Not clinician-reviewed. Drug code 2641.Report inaccuracy

Usage Guidelines

Shake suspension well before each instillation. Instill one drop into conjunctival sac 2 to 4 times daily. Taper under medical supervision.

General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.

Possible Side Effects

Common: Localized stinging, burning, eyelid itching, conjunctival erythema. Rare/Severe: Elevation of intraocular pressure, delayed wound healing, and secondary fungal keratitis.

*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.

Precautions & Warnings

Contraindicated in herpes simplex keratitis. Monitor IOP during prolonged therapy. Discard 4 weeks after opening.

Schedule H (Prescription Required)

This medication is scheduled under statutory drug regulatory frameworks (CDSCO / Drugs & Cosmetics Rules). Dispensing requires a valid medical prescription from a registered medical practitioner. Self-medication or unsupervised dosage adjustment carries significant clinical risks.

Medical Disclaimer: Statutory Clinical Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice, clinical diagnosis, or ophthalmic treatment recommendations. Always consult a registered ophthalmologist or ENT specialist before initiating, changing, or instilling any ophthalmic or otic medication.